Black Rock Inc. Evoke Pharma Inc Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Evoke Pharma Inc stock. As of the latest transaction made, Black Rock Inc. holds 1,464 shares of EVOK stock, worth $688. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,464

Previous 1,464 -0.0%

Holding current value

$688

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$0.59 - $1.07 $5 - $9	-9 Reduced 0.61%	1,464 $0
Q1 2023 May 12, 2023	SELL	$1.89 - $5.75 $11,942 - $36,334	-6,319 Reduced 81.1%	1,473 $2,000
Q4 2022 Feb 13, 2023	SELL	$1.44 - $2.68 $266 - $495	-185 Reduced 2.32%	7,792 $20,000
Q3 2022 Nov 14, 2022	SELL	$1.95 - $3.43 $555 - $977	-285 Reduced 3.45%	7,977 $15,000
Q2 2022 Aug 12, 2022	BUY	$2.04 - $10.32 $16,854 - $85,263	8,262 New	8,262 $27,000

Others Institutions Holding EVOK

# of Institutions

Shares Held

1.46K

Call Options Held

Put Options Held

View Full List

About Evoke Pharma Inc

Ticker EVOK
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,343,070
Market Cap $1.57M
Description
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabeti...

More about EVOK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account